Cargando…

Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

IMPORTANCE: Previous studies have indicated that liver cirrhosis is associated with hypoglycemia, but there have been no studies investigating the association between nonalcoholic fatty liver disease (NAFLD) and hypoglycemia in noncirrhotic populations with type 2 diabetes. OBJECTIVE: To explore the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ji-Yeon, Kim, Young-eun, Han, Kyungdo, Han, Eugene, Lee, Byung Wan, Kang, Eun Seok, Cha, Bong-Soo, Ko, Seung-Hyun, Lee, Yong-ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867244/ https://www.ncbi.nlm.nih.gov/pubmed/35195697 http://dx.doi.org/10.1001/jamanetworkopen.2022.0262

Ejemplares similares

Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Kim, Gyuri, et al.
Publicado: (2015)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
por: Lee, Yong-ho, et al.
Publicado: (2019)

Anatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008–2011)
por: Han, Eugene, et al.
Publicado: (2017)

Corrigenda: Table Correction. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
por: Lee, Yong-ho, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
por: Kim, Kyung-Soo, et al.
Publicado: (2019)

Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
por: Han, Eugene, et al.
Publicado: (2020)

Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study
por: Yun, Jae-Seung, et al.
Publicado: (2019)

Impact of diabetes mellitus and chronic liver disease on the incidence of dementia and all-cause mortality among patients with dementia
por: Kim, Hyun Min, et al.
Publicado: (2017)

The effects of the voglibose on non-alcoholic fatty liver disease in mice model
por: Bae, Jaehyun, et al.
Publicado: (2022)

Association between dietary acid load and the risk of cardiovascular disease: nationwide surveys (KNHANES 2008–2011)
por: Han, Eugene, et al.
Publicado: (2016)

Optimal Candidates for the Switch from Glimepiride to Sitagliptin to Reduce Hypoglycemia in Patients with Type 2 Diabetes Mellitus
por: Kim, Hyun Min, et al.
Publicado: (2015)

Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
por: You, Sang Youn, et al.
Publicado: (2021)

External validation and clinical application of the predictive model for severe hypoglycemia
por: Yun, Jae-Seung, et al.
Publicado: (2022)

The renal tubular damage marker urinary N-acetyl-β-d-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes
por: Kim, So Ra, et al.
Publicado: (2017)

Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Han, Eugene, et al.
Publicado: (2022)

Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Hye Won, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea
por: Chung, Goh Eun, et al.
Publicado: (2021)

Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes
por: Yoon, Hye-jin, et al.
Publicado: (2015)

Combined Effects of Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease on the Risk of Cardiovascular Disease in Patients with Diabetes
por: Chung, Goh-Eun, et al.
Publicado: (2022)

Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease
por: Kim, Mi Na, et al.
Publicado: (2021)

Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
por: Lee, Sejeong, et al.
Publicado: (2023)

Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
por: Han, Eugene, et al.
Publicado: (2023)

The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study
por: Lee, Jung-Min, et al.
Publicado: (2020)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Pre-sarcopenia is associated with renal hyperfiltration independent of obesity or insulin resistance: Nationwide Surveys (KNHANES 2008–2011)
por: Han, Eugene, et al.
Publicado: (2017)

Association between organochlorine pesticides and nonalcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003–2004
por: Sang, Hyunji, et al.
Publicado: (2022)

Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Kim, Tae Hyung, et al.
Publicado: (2021)

Adherence to healthy lifestyle behaviors as a preventable risk factor for severe hypoglycemia in people with type 2 diabetes: A longitudinal nationwide cohort study
por: Yun, Jae‐Seung, et al.
Publicado: (2022)

Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia
por: Han, Eugene, et al.
Publicado: (2016)

Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
por: Lee, Hyeok-Hee, et al.
Publicado: (2020)

Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus
por: Han, Eugene, et al.
Publicado: (2018)

Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
por: Cho, Yongin, et al.
Publicado: (2022)

Impact of Evolutionary Changes in Nonalcoholic Fatty Liver Disease on Lung Function Decline
por: Lee, Hyun Woo, et al.
Publicado: (2023)

Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Baek, Jung-Hwan, et al.
Publicado: (2023)

Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies
por: Lee, Yong-ho, et al.
Publicado: (2016)

The effect of metabolic dysfunction-associated fatty liver disease and diabetic kidney disease on the risk of hospitalization of heart failure in type 2 diabetes: a retrospective cohort study
por: Lee, Seung Eun, et al.
Publicado: (2023)

Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
por: Han, Eugene, et al.
Publicado: (2017)

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
por: Lee, Byung-Wan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s9odpdgcdd7aq9q1rq79iabvd7